Buy-rated reports

511 tickers rated Buy
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Klaviyo, Inc.
KVYO·Technology
A ★★★★Buy
Current$20.71
Target$27.20
Return+31.3%
Nov 7, 2026

Klaviyo combines expanding enterprise adoption, recurring CRM revenue, and improving cash flow with a reasonable valuation, although slowing revenue growth, competition, and stock-based compensation may constrain shareholder returns.

Score
75
Magnite, Inc.
MGNI·Communication Services
A ★★★★Buy
Current$27.39
Target$28.05
Return+2.4%
Nov 7, 2026

Magnite can compound earnings through CTV advertising growth and stronger platform margins, but competitive pressure, advertising cyclicality, and a valuation already reflecting substantial progress limit near-term upside.

Score
75
STERIS plc
STE·Healthcare
A ★★★★Buy
Current$252.30
Target$272.80
Return+8.1%
Nov 7, 2026

STERIS combines recurring infection-prevention revenue, specialized sterilization infrastructure, and durable healthcare demand, but its premium cash-flow valuation and debt-financed Xodus acquisition constrain near-term upside.

Score
75
McKesson Corporation
MCK·Healthcare
A ★★★★Buy
Current$1,060.84
Target$1,113.86
Return+5.0%
Nov 7, 2026

McKesson combines a dominant pharmaceutical distribution network with growing specialty healthcare profits and strong capital efficiency, but its premium valuation and narrow wholesale margins limit the margin of safety.

Score
75
Emerson Electric Co.
EMR·Industrials
A ★★★★Buy
Current$162.35
Target$166.75
Return+2.7%
Nov 7, 2026

Emerson combines durable industrial automation switching costs, rising software profitability, and strong cash generation, although its elevated historical valuation and acquisition-heavy capital base limit the margin of safety.

Score
75
Cinemark Holdings, Inc.
CNK·Communication Services
A ★★★★Buy
Current$40.04
Target$48.97
Return+22.3%
Nov 6, 2026

Cinemark offers compelling earnings recovery and premium-format growth supported by stronger margins and cash generation, although film-slate dependence and financial leverage create substantial cyclical risk.

Score
75
Henry Schein, Inc.
HSIC·Healthcare
A ★★★★Buy
Current$85.31
Target$98.60
Return+15.6%
Nov 6, 2026

Henry Schein offers a healthcare distribution earnings-recovery opportunity supported by share gains, margin expansion, and buybacks, although elevated leverage and modest returns on invested capital constrain its upside.

Score
75
Arista Networks, Inc.
ANET·Technology
A ★★★★Buy
Current$159.16
Target$205.96
Return+29.4%
Nov 6, 2026

Arista Networks combines a durable Ethernet networking moat with exceptional profitability and structural AI infrastructure demand, although demanding growth expectations and hyperscaler concentration create meaningful downside sensitivity.

Score
75
Calix, Inc.
CALX·Technology
A ★★★★Buy
Current$33.85
Target$47.30
Return+39.7%
Nov 5, 2026

Calix combines recovering broadband equipment demand with growing high-margin cloud and AI services at a moderate revenue valuation, although hardware cost inflation and uncertain software monetization could delay margin expansion.

Score
75
Grab Holdings Limited
GRAB·Technology
A ★★★★Buy
Current$3.36
Target$4.88
Return+45.2%
Nov 5, 2026

Grab's expanding Southeast Asian superapp ecosystem and improving operating leverage offer attractive long-term earnings growth, although competitive incentives, financial services credit risk, and acquisition spending could constrain shareholder returns.

Score
75
Broadstone Net Lease, Inc.
BNL·Real Estate
A ★★★★Buy
Current$17.13
Target$19.56
Return+14.2%
Nov 2, 2026

Broadstone Net Lease offers attractive dividend income and growth from long-term industrial leases and build-to-suit developments, but leverage, tenant risk, and forward-equity dilution could limit AFFO-per-share gains.

Score
75
Millrose Properties, Inc.
MRP·Real Estate
A ★★★★Buy
Current$25.62
Target$29.88
Return+16.6%
Nov 2, 2026

Millrose combines recurring homesite financing income, rising AFFO, and an unusually high dividend yield at a modest earnings multiple, but Lennar concentration, funding sensitivity, and securities litigation limit conviction.

Score
75